betamethasone and Cancer of Prostate

betamethasone has been researched along with Cancer of Prostate in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Chaiswing, L; Clair, DS; Ellingson, SR; He, D; Lu, J; Luo, W; Meyer, K; St Clair, W; Thorson, J; Wang, C; Xu, F; Zhao, Y; Zhong, W	1
Antoniou, N; Delis, A; Deliveliotis, C; Papatsoris, A; Varkarakis, IM	1
Fukui, I; Kawakami, S; Ohkubo, Y; Tatokoro, M; Tsukamoto, T; Yamamoto, S; Yonese, J	1
Cavcić, J; Jelincić, Z; Martinac, P; Panijan-Pezerović, R; Turcić, J; Unusić, J; Zupancić, B	1

Trials

2 trial(s) available for betamethasone and Cancer of Prostate

Article	Year
Local steroid application during nerve-sparing radical retropubic prostatectomy. BJU international, 2005, Volume: 96, Issue:4 Topics: Betamethasone; Chi-Square Distribution; Erectile Dysfunction; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Penile Erection; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Urinary Incontinence	2005
Metronidazole in the treatment of chronic radiation proctitis: clinical trial. Croatian medical journal, 2000, Volume: 41, Issue:3 Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Chronic Disease; Drug Therapy, Combination; Enema; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Proctitis; Prostatic Neoplasms; Radiation Injuries; Treatment Outcome	2000

Article

Year

Local steroid application during nerve-sparing radical retropubic prostatectomy.

BJU international, 2005, Volume: 96, Issue:4

Topics: Betamethasone; Chi-Square Distribution; Erectile Dysfunction; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Penile Erection; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Urinary Incontinence

2005

Metronidazole in the treatment of chronic radiation proctitis: clinical trial.

Croatian medical journal, 2000, Volume: 41, Issue:3

Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Chronic Disease; Drug Therapy, Combination; Enema; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Proctitis; Prostatic Neoplasms; Radiation Injuries; Treatment Outcome

2000

Other Studies

2 other study(ies) available for betamethasone and Cancer of Prostate

Article	Year
The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer. International journal of molecular sciences, 2022, Jun-08, Volume: 23, Issue:12 Topics: Adaptor Proteins, Signal Transducing; Betamethasone; Humans; Male; Oxidation-Reduction; Prostatic Neoplasms; Radiation Tolerance; Reactive Oxygen Species; Transcription Factor RelB	2022
Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer. International journal of clinical oncology, 2006, Volume: 11, Issue:4 Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bone Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Flutamide; Glucocorticoids; Gonadotropin-Releasing Hormone; Humans; Male; Neoadjuvant Therapy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms	2006

Article

Year

The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer.

International journal of molecular sciences, 2022, Jun-08, Volume: 23, Issue:12

Topics: Adaptor Proteins, Signal Transducing; Betamethasone; Humans; Male; Oxidation-Reduction; Prostatic Neoplasms; Radiation Tolerance; Reactive Oxygen Species; Transcription Factor RelB

2022

Possibility of recovery of estrogen sensitivity following high-dose glucocorticoid therapy in a patient with hormone-refractory prostate cancer.

International journal of clinical oncology, 2006, Volume: 11, Issue:4

Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bone Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Estrogens; Flutamide; Glucocorticoids; Gonadotropin-Releasing Hormone; Humans; Male; Neoadjuvant Therapy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms

2006